1. Identifying fibroblast growth factor receptor genetic alterations using RNA‐based assays in patients with metastatic or locally advanced, surgically unresectable, urothelial carcinoma who may benefit from erdafitinib treatment. (18th April 2020) Authors: Wang, Songbai; Burgess, Mike; Major, Christopher; English, Alistair; Sweeney, Maranna; Hartmann, Arndt Journal: Journal of pathology Issue: Volume 6:Number 3(2020) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗